Recent years have witnessed groundbreaking advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://blancheilds154117.blogpostie.com/60151747/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements